ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Mammography Guidelines Tightened For BCDDP; September Consensus Meeting Planned

May 13, 1977

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

ACS To Implement Cancer Response Systems Nationwide

August 2, 1985